A carregar...
Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials
INTRODUCTION: Erythropoiesis-stimulating agents and iron are commonly used in patients with chronic kidney disease with the aim of correcting anemia and maintaining stable hemoglobin levels. We analyzed pooled data from 13 studies with similar designs included in the Umbrella Continuous Erythropoiet...
Na minha lista:
Publicado no: | Adv Ther |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer Healthcare
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4846713/ https://ncbi.nlm.nih.gov/pubmed/26965694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0309-6 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|